Page 21 - Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine
P. 21

Life 2021, 11, 784                                                                                 21 of 26



        29.  Cheng, L.; Zhang, K.; Wu, S.; Cui, M.; Xu, T. Focus on Mesenchymal Stem Cell-Derived Exosomes: Opportunities and Challenges
             in Cell-Free Therapy. Stem Cells Int. 2017, 2017, 1–10. [CrossRef]
        30.  Haider, K.H.; Aramini, B. Mircrining the injured heart with stem cell-derived exosomes: An emerging strategy of cell-free therapy.
            Stem Cell Res. Ther. 2020, 11, 1–12. [CrossRef] [PubMed]
        31.  Motavaf, M.; Pakravan, K.; Babashah, S.; Malekvandfard, F.; Masoumi, M.; Sadeghizadeh, M. Therapeutic application of
             mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine. Cell Mol. Biol.
             2016, 62, 74–79.
        32.  Théry, C.; Amigorena, S.; Raposo, G.; Clayton, A. Isolation and Characterization of Exosomes from Cell Culture Supernatants and
             Biological Fluids. Curr. Protoc. Cell Biol. 2006, 30, 3.22.1–3.22.29. [CrossRef] [PubMed]
        33.  Li, P.; Kaslan, M.; Lee, S.H.; Yao, J.; Gao, Z. Progress in Exosome Isolation Techniques. Theranostics 2017, 7, 789–804. [CrossRef]
        34.  Johnstone, R.M.; Adam, M.; Hammond, J.R.; Orr, L.; Turbide, C. Vesicle formation during reticulocyte maturation. Association of
            plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 1987, 262, 9412–9420. [CrossRef]
        35.  Kim, J.; Tan, Z.; Lubman, D.M. Exosome enrichment of human serum using multiple cycles of centrifugation. Electrophoresis 2015,
             36, 2017–2026. [CrossRef] [PubMed]
        36.  Jeppesen, D.; Hvam, M.L.; Primdahl-Bengtson, B.; Boysen, A.T.; Whitehead, B.; Dyrskjøt, L.; Ørntoft, T.F.; Howard, K.A.;
             Ostenfeld, M.S. Comparative analysis of discrete exosome fractions obtained by differential centrifugation. J. Extracell. Vesicles
             2014, 3, 25011. [CrossRef] [PubMed]
        37.  Gupta, S.; Rawat, S.; Arora, V.; Kottarath, S.K.; Dinda, A.K.; Vaishnav, P.K.; Nayak, B.; Mohanty, S. An improvised one-step
             sucrose cushion ultracentrifugation method for exosome isolation from culture supernatants of mesenchymal stem cells. Stem
            Cell Res. Ther. 2018, 9, 180. [CrossRef] [PubMed]
        38.  Xu, Y.; Ku, X.; Wu, C.; Cai, C.; Tang, J.; Yan, W. Exosomal proteome analysis of human plasma to monitor sepsis progression.
            Biochem. Biophys. Res. Commun. 2018, 499, 856–861. [CrossRef] [PubMed]
        39.  Lobb, R.; Becker, M.; Wen, S.W.; Wong, C.S.F.; Wiegmans, A.P.; Leimgruber, A.; Möller, A. Optimized exosome isolation protocol
             for cell culture supernatant and human plasma. J. Extracell. Vesicles 2015, 4, 27031. [CrossRef] [PubMed]
        40.  Yamashita, T.; Takahashi, Y.; Nishikawa, M.; Takakura, Y. Effect of exosome isolation methods on physicochemical properties of
             exosomes and clearance of exosomes from the blood circulation. Eur. J. Pharm. Biopharm. 2016, 98, 1–8. [CrossRef]
        41.  Helwa, I.; Cai, J.; Drewry, M.D.; Zimmerman, A.; Dinkins, M.B.; Khaled, M.L.; Seremwe, M.; Dismuke, W.M.; Bieberich, E.; Stamer,
            W.D.; et al. A Comparative Study of Serum Exosome Isolation Using Differential Ultracentrifugation and Three Commercial
             Reagents. PLoS ONE 2017, 12, e0170628. [CrossRef] [PubMed]
        42.  Ding, M.; Wang, C.; Lu, X.; Zhang, C.; Zhou, Z.; Chen, X.; Zhang, C.-Y.; Zen, K.; Zhang, C. Comparison of commercial exosome
             isolation kits for circulating exosomal microRNA profiling. Anal. Bioanal. Chem. 2018, 410, 3805–3814. [CrossRef]
        43.  Patel, G.K.; Khan, M.A.; Zubair, H.; Srivastava, S.K.; Khushman, M.; Singh, S.; Singh, A. Comparative analysis of exosome
             isolation methods using culture supernatant for optimum yield, purity and downstream applications. Sci. Rep. 2019, 9, 5335.
             [CrossRef]
        44.  Ryu, K.J.; Lee, J.Y.; Park, C.; Cho, D.; Kim, S.J. Isolation of Small Extracellular Vesicles From Human Serum Using a Combination
             of Ultracentrifugation With Polymer-Based Precipitation. Ann. Lab. Med. 2020, 40, 253–258. [CrossRef]
        45.  Théry, C.; Witwer, K.W.; Aikawa, E.; Alcaraz, M.J.; Anderson, J.D.; Andriantsitohaina, R.; Antoniou, A.; Arab, T.; Archer, F.;
            Atkin-Smith, G.K.; et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the
             International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018, 7, 1535750.
             [CrossRef] [PubMed]
        46.  Kowal, J.; Arras, G.; Colombo, M.; Jouve, M.; Morath, J.P.; Primdal-Bengtson, B.; Dingli, F.; Loew, D.; Tkach, M.; Théry, C.
             Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc.
             Natl. Acad. Sci. USA 2016, 113, E968–E977. [CrossRef] [PubMed]
        47.  Caradec, J.; Kharmate, G.; Hosseini-Beheshti, E.; Adomat, H.; Gleave, M.; Guns, E. Reproducibility and efficiency of serum-derived
             exosome extraction methods. Clin. Biochem. 2014, 47, 1286–1292. [CrossRef] [PubMed]
        48.  Mizutani, K.; Terazawa, R.; Kameyama, K.; Kato, T.; Horie, K.; Tsuchiya, T.; Seike, K.; Ehara, H.; Fujita, Y.; Kawakami, K.; et al.
             Isolation of prostate cancer-related exosomes. Anticancer. Res. 2014, 34, 3419–3423. [PubMed]
        49.  Van Deun, J.; Mestdagh, P.; Sormunen, R.; Cocquyt, V.; Vermaelen, K.; Vandesompele, J.; Bracke, M.; De Wever, O.; Hendrix, A.
            The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell. Vesicles 2014, 3.
             [CrossRef] [PubMed]
        50.  Schageman, J.; Zeringer, E.; Li, M.; Barta, T.; Lea, K.; Gu, J.; Magdaleno, S.; Setterquist, R.; Vlassov, A.V. The Complete Exosome
            Workflow Solution: From Isolation to Characterization of RNA Cargo. BioMed Res. Int. 2013, 2013. [CrossRef] [PubMed]
        51.  King, H.W.; Michael, M.Z.; Gleadle, J.M. Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer 2012, 12,
             421. [CrossRef]
        52.  Morel, L.; Regan, M.; Higashimori, H.; Ng, S.K.; Esau, C.; Vidensky, S.; Rothstein, J.; Yang, Y. Neuronal Exosomal miRNA-
             dependent Translational Regulation of Astroglial Glutamate Transporter GLT1. J. Biol. Chem. 2013, 288, 7105–7116. [CrossRef]
             [PubMed]
        53.  Zhang, H.-G.; Liu, C.; Su, K.; Yu, S.; Zhang, L.; Zhang, S.; Wang, J.; Cao, X.; Grizzle, W.; Kimberly, R. A Membrane Form of TNF-α
             Presented by Exosomes Delays T Cell Activation-Induced Cell Death. J. Immunol. 2006, 176, 7385–7393. [CrossRef]
   16   17   18   19   20   21   22   23   24   25   26